Atlas Trials

A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.

Clinical trial NCT01876550 · COMPLETED

Trial details

NCT number
NCT01876550
Sponsor
Sun Pharmaceutical Industries, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Secondarily Infected Traumatic Skin Lesions
Start date
2013-02-01
Primary completion
2014-02-01
Enrollment
1902

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.